BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©The Author(s) 2022.
World J Gastrointest Surg. May 27, 2022; 14(5): 409-418
Published online May 27, 2022. doi: 10.4240/wjgs.v14.i5.409
Table 2 Patient and tumour characteristics
Characteristic
LRH, n = 29
ORH, n = 22
P value
Age64 (57.5-67.5)65.5 (59.75-69.25)0.607
Sex 0.688
Male25 (86.2)20 (90.9)
Female4 (13.8)2 (9.1)
Cirrhosis on histology19 (65.5)13 (59.1)0.638
HBsAg-positive27 (93.1)20 (90.9)1.000
Albumin in g/L39 (36-41)36 (34-40)0.109
Total bilirubin in µmol/L17 (13-20)13 (10-16)0.007
International normalized ratio1.1 (1.05-1.20)1.085 (1.055-1.148)0.587
Platelet count as × 109/L123 (99-173)161.5 (115.25-201.00)0.092
Alpha-fetoprotein in IU/mL11 (4.25-288.00)17 (4.0-174.5)0.814
Type of resection 0.055
Sub-segmentectomy19 (65.5)8 (36.4)
Segmentectomy5 (17.2)2 (9.1)
Left lateral sectionectomy2 (6.9)1 (4.5)
Right bisegmentectomy1 (3.4)4 (18.2)
Left hepatectomy +/− extended1 (3.4)1 (4.5)
Right hepatectomy +/− extended1 (3.4)5 (22.7)
Central bisectionectomy0 (0.0)1 (4.5)
Intraoperative ablation1 (3.4)2 (9.1)0.571
Tumour size in cm 0.054
< 12 (6.9)1 (4.5)
≥ 1-215 (51.7)7 (31.8)
≥ 2-35 (17.2)3 (13.6)
≥ 3-45 (17.2)2 (9.1)
≥ 4-51 (3.4)8 (36.4)
≥ 51 (3.4)1 (4.5)
Number of tumours0.295
Single25 (86.2)16 (72.7)
Multiple4 (13.8)6 (27.3)
Tumour location, segment 0.491
I2 (6.9)0 (0.0)
II, III, IV, V, VI14 (48.3)9 (40.9)
VII, VIII13 (44.8)13 (59.1)


Write to the Help Desk